US Stock MarketDetailed Quotes

IVBIY INNOVENT BIOLOGICS INC UNSPON ADS EACH REP 4 ORD SHS

Watchlist

22.000
0.0000.00%

15min DelayClose Sep 18 16:00 ET

8.92BMarket Cap-48140P/E (TTM)

INNOVENT BIOLOGICS INC UNSPON ADS EACH REP 4 ORD SHS Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Total revenue

36.21%6.21B

6.71%4.56B

11.08%4.27B

266.94%3.84B

1.05B

Operating revenue

36.21%6.21B

6.71%4.56B

11.08%4.27B

266.94%3.84B

--1.05B

Cost of revenue

22.05%1.14B

84.23%930.99M

30.32%505.34M

210.51%387.76M

124.88M

Gross profit

39.84%5.07B

-3.69%3.63B

8.92%3.76B

274.58%3.46B

922.65M

Operating expense

-3.68%5.98B

8.83%6.21B

63.03%5.7B

58.94%3.5B

2.2B

Selling and administrative expenses

12.40%3.85B

0.00%3.43B

92.73%3.43B

87.56%1.78B

--947.81M

-Selling and marketing expense

19.68%3.1B

-1.12%2.59B

95.41%2.62B

93.62%1.34B

--692.52M

-General and administrative expense

-10.20%750.28M

3.66%835.49M

84.50%806.01M

71.12%436.87M

--255.3M

Research and development costs

-22.42%2.23B

23.63%2.87B

25.44%2.32B

43.00%1.85B

--1.29B

Operating profit

64.79%-909.21M

-33.15%-2.58B

-4,468.83%-1.94B

96.68%-42.44M

-1.28B

Net non-operating interest income expense

303.25%354.21M

-1.63%87.84M

86.99%89.29M

10.51%47.75M

43.21M

Non-operating interest income

138.92%452.84M

24.90%189.54M

30.71%151.76M

13.05%116.1M

--102.7M

Non-operating interest expense

-3.02%98.62M

62.81%101.7M

-8.61%62.46M

14.89%68.35M

--59.49M

Other net income (expense)

Special income (charges)

-1,686.67%-952K

108.46%60K

40.92%-709K

---1.2M

--0

-Less:Other special charges

1,686.67%952K

-108.46%-60K

-40.92%709K

--1.2M

----

Other non- operating income (expenses)

-56.83%-680.09M

39.56%-433.64M

-86.80%-717.42M

23.15%-384.06M

---499.73M

Income before tax

47.27%-1.14B

17.84%-2.17B

-207.64%-2.64B

50.07%-858.71M

-1.72B

Income tax

-1,423.69%-116.5M

-89.89%8.8M

-37.70%87.04M

139.71M

Net income

52.83%-1.03B

20.14%-2.18B

-173.31%-2.73B

41.95%-998.42M

-1.72B

Net income continuous Operations

52.83%-1.03B

20.14%-2.18B

-173.31%-2.73B

41.95%-998.42M

---1.72B

Minority interest income

Net income attributable to the parent company

52.83%-1.03B

20.14%-2.18B

-173.31%-2.73B

41.95%-998.42M

-1.72B

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

52.83%-1.03B

20.14%-2.18B

-173.31%-2.73B

41.95%-998.42M

-1.72B

Basic earnings per share

54.79%-2.64

22.34%-5.84

-154.05%-7.52

49.32%-2.96

-5.84

Diluted earnings per share

54.79%-2.64

22.34%-5.84

-154.05%-7.52

49.32%-2.96

-5.84

Dividend per share

Currency Unit

CNY

Accounting Standards

NonUS-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Total revenue	36.21%6.21B	6.71%4.56B	11.08%4.27B	266.94%3.84B	1.05B
Operating revenue	36.21%6.21B	6.71%4.56B	11.08%4.27B	266.94%3.84B	--1.05B
Cost of revenue	22.05%1.14B	84.23%930.99M	30.32%505.34M	210.51%387.76M	124.88M
Gross profit	39.84%5.07B	-3.69%3.63B	8.92%3.76B	274.58%3.46B	922.65M
Operating expense	-3.68%5.98B	8.83%6.21B	63.03%5.7B	58.94%3.5B	2.2B
Selling and administrative expenses	12.40%3.85B	0.00%3.43B	92.73%3.43B	87.56%1.78B	--947.81M
-Selling and marketing expense	19.68%3.1B	-1.12%2.59B	95.41%2.62B	93.62%1.34B	--692.52M
-General and administrative expense	-10.20%750.28M	3.66%835.49M	84.50%806.01M	71.12%436.87M	--255.3M
Research and development costs	-22.42%2.23B	23.63%2.87B	25.44%2.32B	43.00%1.85B	--1.29B
Operating profit	64.79%-909.21M	-33.15%-2.58B	-4,468.83%-1.94B	96.68%-42.44M	-1.28B
Net non-operating interest income expense	303.25%354.21M	-1.63%87.84M	86.99%89.29M	10.51%47.75M	43.21M
Non-operating interest income	138.92%452.84M	24.90%189.54M	30.71%151.76M	13.05%116.1M	--102.7M
Non-operating interest expense	-3.02%98.62M	62.81%101.7M	-8.61%62.46M	14.89%68.35M	--59.49M
Other net income (expense)
Special income (charges)	-1,686.67%-952K	108.46%60K	40.92%-709K	---1.2M	--0
-Less:Other special charges	1,686.67%952K	-108.46%-60K	-40.92%709K	--1.2M	----
Other non- operating income (expenses)	-56.83%-680.09M	39.56%-433.64M	-86.80%-717.42M	23.15%-384.06M	---499.73M
Income before tax	47.27%-1.14B	17.84%-2.17B	-207.64%-2.64B	50.07%-858.71M	-1.72B
Income tax	-1,423.69%-116.5M	-89.89%8.8M	-37.70%87.04M	139.71M	0
Net income	52.83%-1.03B	20.14%-2.18B	-173.31%-2.73B	41.95%-998.42M	-1.72B
Net income continuous Operations	52.83%-1.03B	20.14%-2.18B	-173.31%-2.73B	41.95%-998.42M	---1.72B
Minority interest income
Net income attributable to the parent company	52.83%-1.03B	20.14%-2.18B	-173.31%-2.73B	41.95%-998.42M	-1.72B
Preferred stock dividends
Other preferred stock dividends	0	0	0	0	0
Net income attributable to common stockholders	52.83%-1.03B	20.14%-2.18B	-173.31%-2.73B	41.95%-998.42M	-1.72B
Basic earnings per share	54.79%-2.64	22.34%-5.84	-154.05%-7.52	49.32%-2.96	-5.84
Diluted earnings per share	54.79%-2.64	22.34%-5.84	-154.05%-7.52	49.32%-2.96	-5.84
Dividend per share
Currency Unit	CNY	CNY	CNY	CNY	CNY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data